PSY37 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 600/800mg Daily as Therapy for Imatinib Failing Chronic Myeloid Leukemia (CML)

✍ Scribed by M. Taylor; S. Mealing; D. Scott; J. Clark; M. McKenna; M. Lebmeier; C. Davis

• Book ID: 119311504
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 61 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.03.571